Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1285

1.

NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.

Bansal N, Katz R, Dalrymple L, de Boer I, DeFilippi C, Kestenbaum B, Park M, Sarnak M, Seliger S, Shlipak M.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):205-14. doi: 10.2215/CJN.04910514. Epub 2015 Jan 20.

2.

Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: the Atherosclerosis Risk in Communities study.

Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, Ballantyne CM, Woodward M, Coresh J.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1770-7. doi: 10.1161/ATVBAHA.114.303465. Epub 2014 May 29.

3.

Cystatin C-based CKD-EPI equations and N-terminal pro-B-type natriuretic peptide for predicting outcomes in acutely decompensated heart failure.

Flores-Blanco PJ, Manzano-Fernández S, Pérez-Calvo JI, Pastor-Pérez FJ, Ruiz-Ruiz FJ, Carrasco-Sánchez FJ, Morales-Rull JL, Pascual-Figal D, Galisteo-Almeda L, Januzzi JL.

Clin Cardiol. 2015 Feb;38(2):106-13. doi: 10.1002/clc.22362. Epub 2015 Feb 6.

4.

High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study.

Bansal N, Hyre Anderson A, Yang W, Christenson RH, deFilippi CR, Deo R, Dries DL, Go AS, He J, Kusek JW, Lash JP, Raj D, Rosas S, Wolf M, Zhang X, Shlipak MG, Feldman HI.

J Am Soc Nephrol. 2015 Apr;26(4):946-56. doi: 10.1681/ASN.2014010108. Epub 2014 Oct 2. Erratum in: J Am Soc Nephrol. 2015 Oct;26(10):2599.

5.

Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.

Gregg LP, Adams-Huet B, Li X, Colbert G, Jain N, de Lemos JA, Hedayati SS.

J Am Heart Assoc. 2017 Jul 5;6(7). pii: e005235. doi: 10.1161/JAHA.116.005235.

6.

Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.

Park M, Vittinghoff E, Shlipak MG, Mishra R, Whooley M, Bansal N.

Am Heart J. 2014 Dec;168(6):931-9.e2. doi: 10.1016/j.ahj.2014.09.008. Epub 2014 Oct 14.

7.

Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.

Manzano-Fernández S, Boronat-Garcia M, Albaladejo-Otón MD, Pastor P, Garrido IP, Pastor-Pérez FJ, Martínez-Hernández P, Valdés M, Pascual-Figal DA.

Am J Cardiol. 2009 Jun 15;103(12):1753-9. doi: 10.1016/j.amjcard.2009.02.029.

PMID:
19539088
8.

Serum N-terminal Pro-brain Natriuretic Peptide Level is Associated with the Development of Chronic Kidney Diseases in Patients with Type 2 Diabetes.

Sawada R, Hashimoto Y, Senmaru T, Tanaka M, Ushigome E, Yamazaki M, Fukui M.

Endocr Metab Immune Disord Drug Targets. 2018;18(6):590-595. doi: 10.2174/1871530318666180426112050.

PMID:
29697035
9.

Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.

Kim Y, Matsushita K, Sang Y, Grams ME, Skali H, Shah AM, Hoogeveen RC, Solomon SD, Ballantyne CM, Coresh J.

Am J Kidney Dis. 2015 Apr;65(4):550-8. doi: 10.1053/j.ajkd.2014.08.021. Epub 2014 Oct 23.

10.

Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.

Poortvliet R, de Craen A, Gussekloo J, de Ruijter W.

Age Ageing. 2015 Sep;44(5):841-7. doi: 10.1093/ageing/afv091. Epub 2015 Jul 25.

PMID:
26209786
11.

High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease.

Bjurman C, Petzold M, Venge P, Farbemo J, Fu ML, Hammarsten O.

Clin Biochem. 2015 Mar;48(4-5):302-7. doi: 10.1016/j.clinbiochem.2015.01.008. Epub 2015 Jan 28.

12.

Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.

Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E.

J Am Coll Cardiol. 2008 Aug 5;52(6):450-9. doi: 10.1016/j.jacc.2008.04.033.

13.

Association between Monocyte Count and Risk of Incident CKD and Progression to ESRD.

Bowe B, Xie Y, Xian H, Li T, Al-Aly Z.

Clin J Am Soc Nephrol. 2017 Apr 3;12(4):603-613. doi: 10.2215/CJN.09710916. Epub 2017 Mar 27.

14.

Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).

Driver TH, Shlipak MG, Katz R, Goldenstein L, Sarnak MJ, Hoofnagle AN, Siscovick DS, Kestenbaum B, de Boer IH, Ix JH.

Am J Kidney Dis. 2014 Oct;64(4):534-41. doi: 10.1053/j.ajkd.2014.05.008. Epub 2014 Jun 18.

15.

Comparison between Different Measures of Body Fat with Kidney Function Decline and Incident CKD.

Madero M, Katz R, Murphy R, Newman A, Patel K, Ix J, Peralta C, Satterfield S, Fried L, Shlipak M, Sarnak M.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):893-903. doi: 10.2215/CJN.07010716. Epub 2017 May 18.

16.

Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.

Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Levey AS, Lewis EF, McMurray JJ, Parving HH, Solomon SD, Pfeffer MA.

Am J Kidney Dis. 2011 Nov;58(5):717-28. doi: 10.1053/j.ajkd.2011.05.020. Epub 2011 Aug 5.

PMID:
21820220
17.

Fibroblast growth factor 23 and incident CKD in type 2 diabetes.

Isakova T, Craven TE, Lee J, Scialla JJ, Xie H, Wahl P, Marcovina SM, Byington RP, Wolf M.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):29-38. doi: 10.2215/CJN.06190614. Epub 2014 Oct 24.

18.

Early markers of cardiovascular risk in chronic kidney disease.

Lai S, Dimko M, Galani A, Coppola B, Innico G, Frassetti N, Mazzei ED, Mariotti A.

Ren Fail. 2015 Mar;37(2):254-61. doi: 10.3109/0886022X.2014.982489. Epub 2014 Nov 14.

PMID:
25394527
19.

Blood pressure and chronic kidney disease progression in a multi-racial cohort: the Multi-Ethnic Study of Atherosclerosis.

Bloomfield GS, Yi SS, Astor BC, Kramer H, Shea S, Shlipak MG, Post WS.

J Hum Hypertens. 2013 Jul;27(7):421-6. doi: 10.1038/jhh.2013.1. Epub 2013 Feb 14.

20.

Serum metabolomic profiling and incident CKD among African Americans.

Yu B, Zheng Y, Nettleton JA, Alexander D, Coresh J, Boerwinkle E.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1410-7. doi: 10.2215/CJN.11971113. Epub 2014 Jul 10.

Supplemental Content

Support Center